Mer­ck dives deep­er in­to KRAS, team­ing up with Tai­ho, As­tex to de­vel­op small mol­e­cule drugs

6 years ago
Deals

The list gets longer: Mer­ck, Al­ler­gan, No­var­tis is­sue 2020 drug price hikes — re­port

6 years ago
Pharma

FDA of­fers As­traZeneca a short­cut on a land­mark SGLT2 ap­proval while Chi­na green­lights Lokel­ma

6 years ago
Pharma
FDA+

FDA rushed to ap­prove new drugs in 2019, some­times way ahead of sched­ule. Could that be dan­ger­ous?

6 years ago
FDA+

J&J drops its op­tion on Proven­tion Bio drug af­ter tri­al fail­ure

6 years ago
R&D

IQVIA vet takes the helm at Chi­na's Foun­tain Med­ical; Michael Nazak pro­mot­ed to CFO post at Aridis

6 years ago
Peer Review

Clin­i­cal un­cer­tain­ty, price push­es UK's NICE to spurn Akcea's Waylivra

6 years ago
FDA+

Bank­rupt uBio­me sells off patents, da­ta for $7M; J&J buys op­tions on Pul­ma­trix's lung can­cer drugs

6 years ago
News Briefing

Re­gen­eron brings out the bud­get ax as ex­ecs cut staff in the wake of re­vis­ing al­liance with Sanofi

6 years ago
R&D

Il­lu­mi­na's $1.2B buy­out dies amid FTC 'mo­nop­o­list' ac­cu­sa­tion

6 years ago
Deals

Of­fer­ing much need­ed re­lief for Wood­ford-as­so­ci­at­ed funds, se­quenc­ing uni­corn Ox­ford Nanopore rais­es $105.9M in new ...

6 years ago
Financing

Cash-strapped No­van takes a hard knock as mol­lus­cum drug fiz­zles in late-stage tri­als

6 years ago
R&D

In­cyte takes a beat­ing as a key PhI­II study flops in their lat­est painful set­back — block­buster hopes crushed

6 years ago
R&D

BeiGene scores first Chi­na OK with PD-1 — to be man­u­fac­tured by Boehringer In­gel­heim

6 years ago
China
Pharma

Durect shares stum­ble as top drug fails mid-stage tri­al

6 years ago
R&D

New year, new (high­er) drug prices

6 years ago
Pharma

Tough times for Tecen­triq as NICE once again slaps down Roche's im­munother­a­py — slight ben­e­fit not worth price

6 years ago
R&D

Biotech bil­lion­aire spends $88M to re­or­ga­nize his long-suf­fer­ing bio­engi­neer­ing busi­ness­es, hands off CEO role

6 years ago
R&D

Chi­na green­lights home­grown pneu­mo­coc­cal, HPV vac­cines for the mar­ket — break­ing grips by Pfiz­er, Mer­ck

6 years ago
China
FDA+

‘No one ex­pects to get a knight­hood’: As­traZeneca’s Mene Pan­ga­los knight­ed for his lead­ing role in UK life ...

6 years ago
People

Decades old tu­ber­cu­lo­sis vac­cine di­rect­ly in­ject­ed in­to veins could tur­bocharge pro­tec­tion, mon­key study finds

6 years ago
R&D

Here are the 52 new drugs ap­proved by the FDA in 2019. Who won? Who lost? And who just sur­vived to 2020?

6 years ago
Special
Pharma

Savara gets FDA break­through sta­tus de­spite large, late-stage fail­ure

6 years ago
R&D
FDA+

De­spite ques­tion­able PARP da­ta, FDA stamps quick OK on Lyn­parza as a front­line ther­a­py for pan­cre­at­ic can­cer

6 years ago
Pharma
First page Previous page 880881882883884885886 Next page Last page
A service from the Financial Times